Log in

NYSE:SYKStryker Stock Price, Forecast & News

$148.07
-1.51 (-1.01 %)
(As of 04/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$146.55
Now: $148.07
$151.83
50-Day Range
$126.50
MA: $181.68
$225.10
52-Week Range
$124.54
Now: $148.07
$226.30
Volume2.06 million shs
Average Volume3.69 million shs
Market Capitalization$55.50 billion
P/E Ratio27.02
Dividend Yield1.54%
Beta0.84
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products that include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. It also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems for use in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 80 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Read More
Stryker logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.3Community Rank: 2.5Dividend Strength: 4.2Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

3.12 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP86366710
Phone269-389-2600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$14.88 billion
Cash Flow$10.36 per share
Book Value$34.23 per share

Profitability

Net Income$2.08 billion

Miscellaneous

Employees40,000
Market Cap$55.50 billion
Next Earnings Date4/28/2020 (Estimated)
OptionableOptionable

Receive SYK News and Ratings via Email

Sign-up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter.


Stryker (NYSE:SYK) Frequently Asked Questions

How has Stryker's stock been impacted by COVID-19 (Coronavirus)?

Stryker's stock was trading at $175.62 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SYK shares have decreased by 15.7% and is now trading at $148.07. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Stryker?

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 1 sell rating, 6 hold ratings and 15 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Stryker.

When is Stryker's next earnings date?

Stryker is scheduled to release its next quarterly earnings announcement on Tuesday, April 28th 2020. View our earnings forecast for Stryker.

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) posted its quarterly earnings data on Tuesday, January, 28th. The medical technology company reported $2.49 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.46 by $0.03. The medical technology company earned $4.13 billion during the quarter, compared to analyst estimates of $4.11 billion. Stryker had a return on equity of 25.75% and a net margin of 13.99%. The business's quarterly revenue was up 8.8% on a year-over-year basis. During the same period in the prior year, the business posted $2.18 EPS. View Stryker's earnings history.

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker announced a quarterly dividend on Friday, February 7th. Stockholders of record on Tuesday, March 31st will be paid a dividend of $0.575 per share on Thursday, April 30th. This represents a $2.30 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date is Monday, March 30th. View Stryker's dividend history.

What guidance has Stryker issued on next quarter's earnings?

Stryker updated its FY20 earnings guidance on Tuesday, January, 28th. The company provided EPS guidance of $9.00-9.20 for the period, compared to the Thomson Reuters consensus estimate of $9.04.

What price target have analysts set for SYK?

22 brokerages have issued 12 month price objectives for Stryker's stock. Their forecasts range from $145.00 to $248.00. On average, they anticipate Stryker's stock price to reach $211.10 in the next year. This suggests a possible upside of 42.6% from the stock's current price. View analysts' price targets for Stryker.

Has Stryker been receiving favorable news coverage?

Media headlines about SYK stock have been trending very negative recently, according to InfoTrie. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Stryker earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave news headlines about the medical technology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutStryker.

Are investors shorting Stryker?

Stryker saw a increase in short interest in March. As of March 13th, there was short interest totaling 5,538,700 shares, an increase of 43.9% from the February 27th total of 3,850,000 shares. Based on an average daily trading volume, of 1,640,000 shares, the days-to-cover ratio is currently 3.4 days. Currently, 1.6% of the company's stock are sold short. View Stryker's Current Options Chain.

Who are some of Stryker's key competitors?

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Walt Disney (DIS), Johnson & Johnson (JNJ), Medtronic (MDT), Visa (V), Home Depot (HD), AbbVie (ABBV), NVIDIA (NVDA), Boeing (BA), Bank of America (BAC) and QUALCOMM (QCOM).

Who are Stryker's key executives?

Stryker's management team includes the following people:
  • Mr. Kevin A. Lobo, Chairman & CEO (Age 54)
  • Mr. Timothy J. Scannell, Pres & COO (Age 54)
  • Mr. Glenn S. Boehnlein, VP & CFO (Age 57)
  • Mr. Michael D. Hutchinson, VP & Chief Legal Officer (Age 48)
  • Mr. Lonny J. Carpenter, Group Pres & Adviser to the CEO (Age 57)

What is Stryker's stock symbol?

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Who are Stryker's major shareholders?

Stryker's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include CWS Financial Advisors LLC (0.08%), Bath Savings Trust Co (0.02%), McGuire Investment Group LLC (0.02%), First Financial Bank Trust Division (0.01%), Cullinan Associates Inc. (0.01%) and Woodstock Corp (0.00%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Lonny J Carpenter, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell and Yin C Becker. View institutional ownership trends for Stryker.

Which major investors are selling Stryker stock?

SYK stock was sold by a variety of institutional investors in the last quarter, including CWS Financial Advisors LLC, Woodstock Corp, and M&R Capital Management Inc.. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Srikant M Datar, and Timothy J Scannell. View insider buying and selling activity for Stryker.

Which major investors are buying Stryker stock?

SYK stock was acquired by a variety of institutional investors in the last quarter, including Cullinan Associates Inc., Bath Savings Trust Co, First Financial Bank Trust Division, Pensionfund Sabic, McGuire Investment Group LLC, and Wiley BROS. Aintree Capital LLC. View insider buying and selling activity for Stryker.

How do I buy shares of Stryker?

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Stryker's stock price today?

One share of SYK stock can currently be purchased for approximately $148.07.

How big of a company is Stryker?

Stryker has a market capitalization of $55.50 billion and generates $14.88 billion in revenue each year. The medical technology company earns $2.08 billion in net income (profit) each year or $8.26 on an earnings per share basis. Stryker employs 40,000 workers across the globe. View additional information about Stryker.

What is Stryker's official website?

The official website for Stryker is http://www.strykercorp.com/.

How can I contact Stryker?

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]

This page was last updated on 4/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel